Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Lack of Ctip2 in skin cells delays wound healing and disrupts hair follicle stem cell markers in mice.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Total skin electron therapy is an effective treatment for mycosis fungoides, balancing effectiveness and side effects.

TAF4 is important for skin cell growth and helps prevent skin cancer in mice.

The SketchAndCalc app is a faster and more precise method for measuring hair transplant areas than traditional grid counting.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Advancements in skin treatment and wound healing include promising gene therapy, 3D skin models, and potential new therapies.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

3D models from confocal microscopy improve melanoma detection on sun-damaged skin.

ERK activation spreads between cells in mouse skin, linked to cell division and influenced by TPA and EGF receptors.

K10 may not prevent tumors as previously thought and might increase benign tumor risk.

AI can greatly improve skin cancer diagnosis and treatment.

The authors created a realistic and efficient method to simulate hair movement by combining fluid dynamics with individual hair strand behavior.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

LRIG1 protein affects hair growth by regulating skin receptors, leading to hair loss when overexpressed.

A new compound shows promise as a topical treatment for hair loss.

A new image-based method improves accuracy in measuring hair loss in mice.

Accidental injection of hyaluronic acid caused temporary hair loss and skin damage, but treatment restored hair and healed the skin.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Dkk4 is necessary for the initial development and arrangement of hair follicles.

Mathematical modeling helps understand and predict the MAPK cell signaling pathway.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

TIP39 and PTH2R help control calcium levels and skin cell development.